Table 1.

Long non‐coding RNAs as biomarkers in acute myocardial infarction

	LncRNAs	Regulation after AMI	Relation to other biomarkers
Yan et al. 41	UCA1	Down‐regulation	Inversely related to miR‐1 level
Zangrando et al. 42	MIRT1/MIRT2	Up‐regulation	Negatively correlated with infarct size; positively correlated with EF value
Zhang et al. 43	MHRT	Up‐regulation	Inversely related to cardiomyocyte apoptosis
Vausort et al. 56	ANRIL	Down‐regulation	Positively correlated to lymphocytes and monocytes; negatively related to MMP9, WBC, neutrophils, platelets
Vausort et al. 56	MIAT	Down‐regulation	Positively related to lymphocytes; negatively related to neutrophils, platelets
Vausort et al. 56	MALAT1	Up‐regulation	Negatively related to platelets
Vausort et al. 56	aHIF	Up‐regulation	Positively related to WBC, neutrophils CRP, MMP9, TIMP1; negatively related to lymphocytes
Qu et al. 80	NONMMUT022554	Up‐regulation	Positively correlated with fibrosis gene expression

ANRIL, cyclin‐dependent kinase inhibitor 2B antisense RNA 1; aHIF, hypoxia‐inducible factor 1A antisense RNA 2; CRP, C‐reactive protein; EF, ejection fraction; MIRT1, MI‐associated transcript 1; MIRT2, MI‐associated transcript 2; MIAT, myocardial infarction‐associated transcript; MALAT1. metastasis‐associated lung adenocarcinoma transcript 1; MMP9, matrix metalloproteinase 9; TIMP1, tissue inhibitor of metalloproteinase 1; UCA1, urothelial carcinoma‐associated 1; WBC, white blood cell.